Kathryn Huebner, OD
Optometrist · Washington, DCNPI 1235543851
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $285 and has fallen 59.5% since, to $115 in 2025.
Across 50 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$184
- LKC Technologies, Inc.$117
- Bausch & Lomb, A Division Of Bausch Health US, LLC$108
- Coopervision Inc.$97
- Johnson & Johnson Vision Care, Inc.$91
- AbbVie$85
- plus $418 from 11 others
Across 3 payments — averaging $30.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$90
What the payments were for
- Food & beverage$1,100100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 10 | $184 |
| LKC Technologies, Inc. | 1 | $117 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $108 |
| Coopervision Inc. | 4 | $97 |
| Johnson & Johnson Vision Care, Inc. | 5 | $91 |
| AbbVie(2 entities) | 4 | $85 |
| Harrow Eye, LLC | 3 | $75 |
| Alcon | 3 | $58 |
| Oyster Point Pharma, Inc. | 3 | $52 |
| Novartis | 2 | $43 |
| Biotissue Holdings Inc. | 2 | $42 |
| Tarsus Pharmaceuticals, Inc. | 1 | $34 |
| ABB Con-cise Optical Group LLC | 2 | $32 |
| Oasis Medical, Inc. | 2 | $29 |
| Maculogix, Inc. | 1 | $19 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
How this compares
$1,100 in reported general payments places this provider in the 55th percentile of 71 optometrist providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Washington
- Saba MatternWashington$11K
- Evelyn DearingWashington$5K
- Gregory FoleyWashington$4K
- Nastaran GolrizWashington$4K
- Nguyen WatermanWashington$4K
- Arnold MillerWashington$3K
- Cheryl TranWashington$3K
- Thanh Loan DorsamWashington$3K
- Dalia ElkassabanyWashington$3K
- Nickey NeagleWashington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.